Rasappa Arumugham

Title: Innovations of Rasappa Arumugham

Introduction

Rasappa Arumugham is an accomplished inventor based in Pittsford, NY (US). He has made significant contributions to the field of microbiology, particularly in the development of non-toxic mutants of pathogenic gram-negative bacteria. With a total of 3 patents to his name, his work has the potential to impact public health positively.

Latest Patents

One of Rasappa Arumugham's latest patents focuses on a method for identifying, isolating, and producing htrB mutants of gram-negative bacterial pathogens. This innovative method involves mutating the htrB gene of a gram-negative bacterial pathogen, resulting in a mutant that lacks one or more secondary acyl chains found in the wild type strain. The resulting mutant displays substantially reduced toxicity compared to the wild type strain. Furthermore, the invention provides methods for using a vaccine formulation containing the htrB mutant or the endotoxin isolated from it, which can be conjugated to a carrier protein. This formulation aims to immunize individuals against infections caused by gram-negative bacterial pathogens by administering a prophylactically effective amount of the vaccine.

Career Highlights

Rasappa Arumugham has worked with notable organizations, including the University of Iowa Research Foundation and Wyeth Holdings Corporation. His experience in these institutions has contributed to his expertise in the field of bacterial pathogens and vaccine development.

Collaborations

Throughout his career, Rasappa has collaborated with esteemed colleagues such as Michael A Apicella and Bradford W Gibson. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Rasappa Arumugham's work in developing non-toxic mutants of pathogenic gram-negative bacteria showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his significant contributions to the field.